Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.4M Buy
+1,599,300
New +$17.1M 0.01% 1387
2025
Q4
Sell
-29,000
Closed -$388K 4900
2025
Q3
$388K Buy
29,000
+14,200
+96% +$168K ﹤0.01% 3990
2025
Q2
$189K Buy
+14,800
New +$178K ﹤0.01% 4064
2024
Q4
Sell
-37,600
Closed -$481K 4745
2024
Q3
$481K Sell
37,600
-67,400
-64% -$825K ﹤0.01% 3727
2024
Q2
$1.33M Sell
105,000
-118,500
-53% -$2.05M ﹤0.01% 2989
2024
Q1
$5.07M Buy
+223,500
New +$5.23M ﹤0.01% 1879
2022
Q3
Sell
-278,800
Closed -$5.07M 5437
2022
Q2
$5.07M Buy
+278,800
New +$5.21M 0.01% 2111

Other funds holding PATH

David Shaw's PATH Position: Q2 2026 in Review

David Shaw increased its UiPath (PATH) stake by 303% in Q2 2026, buying an estimated $37.9M and bringing the position to 4,719,704 shares worth $51.3M. The position accounts for 0.02% of the portfolio, ranked #746.

David Shaw first reported a position in PATH in Q2 2021 and has held it in 18 quarters since. The position peaked at $107M in Q2 2025. 525 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

  • David Shaw held 4,719,704 shares of UiPath worth $51.3M as of Q2 2026.
  • David Shaw bought 3,548,801 UiPath shares in Q2 2026, an estimated $37.9M.
  • UiPath made up 0.02% of David Shaw's portfolio in Q2 2026, its #746 holding.
  • David Shaw first reported a position in UiPath in Q2 2021 and has held it in 18 quarters since.
  • David Shaw's UiPath position peaked at $107M in Q2 2025.
  • 525 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.